Pancreatic Cancer Global Clinical Trials Review, H1, 2018

  • ID: 4559047
  • Clinical Trials
  • Region: Global
  • 1460 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celgene Corp
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Merck & Co Inc
  • MORE
Pancreatic Cancer Global Clinical Trials Review, H1, 2018

Summary

The author's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Celgene Corp
  • Eli Lilly and Co
  • F. Hoffmann-La Roche Ltd
  • Merck & Co Inc
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Pancreatic Cancer
  • Apr 18, 2018: BerGenBio: Promising data highlighting selective AXL inhibitor bemcentinib's potential to improve efficacy of checkpoint inhibitors presented at AACR
  • Apr 18, 2018: MabVax Therapeutics Antibody Program Results Featured in Three Presentations at 2018 American Association for Cancer Research (AACR) Annual Meeting
  • Apr 17, 2018: PharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide Study
  • Apr 17, 2018: BERG Announces Data Presentations at AACR 2018 Validating Novel Prostate Cancer Biomarkers and Clinical Activity of BPM 31510 Across Several Metabolic Cancer Types
  • Apr 16, 2018: Syndax to Present on Entinostat at the 2018 American Association for Cancer Research Annual Meeting
  • Apr 16, 2018: Bioatla Announces FDA Clearance Of Investigational New Drug Application For CAB-ROR2-ADC Therapeutic
  • Apr 13, 2018: TyrNovo to Present at 2018 Annual Meeting of the American Association for Cancer Research
  • Apr 12, 2018: TCR2 Therapeutics to Present New Preclinical Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting
  • Apr 12, 2018: AbGenomics Invited to 6th Annual Biologics World Taiwan, Dr. Shih-Yao Lin Speaks
  • Apr 09, 2018: Merrimack to Present Preclinical Data at the 2018 American Association for Cancer Research Annual Meeting
  • Apr 04, 2018: BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer
  • Apr 02, 2018: PharmaCyte Ships Clinical Trial Cells to Austrianova for Encapsulation
  • Mar 26, 2018: Preclinical Data Showing Synergy of Biothera Pharmaceuticals' Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone Symposia
  • Mar 26, 2018: ARMO BioSciences Announces Positive Outcome of First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study
  • Mar 19, 2018: Karyopharm to Present Preclinical Data on KPT-9274 at the American Association for Cancer Research 2018 Annual Meeting
  • Mar 16, 2018: “Recombinant ANTI-EpCAM And ANTI-CD3 Human-Mouse Chimeric Bispecific Antibody For Injection” Was Granted Drug Clinical Trial Approval
  • Mar 15, 2018: MabVax Therapeutics to present interim results from the Phase 1 clinical trial of MVT-1075
  • Mar 14, 2018: FDA Acceptance of IND for Tyme to Begin Phase II Trial in Pancreatic Cancer
  • Mar 08, 2018: TyrNovo to Present at BIO-Europe Spring 2018 Conference
  • Mar 05, 2018: Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage IV Pancreas Cancer in a Phase 1b HITM-SURE Trial (NCT02850536)
  • Mar 01, 2018: Fibrogen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer
  • Feb 28, 2018: MabVax Therapeutics Reports Positive Safety Results from Initial Cohort of MVT-1075 Radioimmunotherapy Phase 1 Trial for the Treatment of Pancreatic, Colon and Lung Cancers
  • Feb 28, 2018: PharmaCyte Discusses Phase 2b Clinical Trial in Pancreatic Cancer
  • Feb 12, 2018: MabVax Therapeutics Announces Positive Interim Data from Expanded Cohort in Phase 1 Trial Evaluating MVT-5873 in Combination with First-Line Chemotherapy in Pancreatic Cancer
  • Feb 07, 2018: MabVax to Present Clinical Update on MVT-5873 at BIO CEO & Investor Conference
  • Feb 07, 2018: MabVax to Present Clinical Update on MVT-1075 (human antibody-based radioimmunotherapy)at BIO CEO & Investor Conference
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Disclaimer
  • Source
List of Tables
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology 1
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Pfizer Inc
  • AstraZeneca Plc
  • Celgene Corp
  • Sanofi
  • Sarah Cannon Research Institute LLC
  • Merck & Co Inc
  • Eli Lilly and Co
  • Bristol-Myers Squibb Co
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll